Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Intracranial haematoma; This is a spontaneous report from a contactable physician downloaded from the Medicines Agency (MA) Regulatory authority-WEB FR-AFSSAPS-PO20210283. An 85-year-old female patient received her first dose of bnt162b2 (COMIRNATY, lot EJ6788), intramuscularly on left arm on 02Feb2021 at single dose for COVID-19 immunization. Medical history included Alzheimer''s disease, Anxiodepressive syndrome, behaviour disorder, atrial fibrillation (AFib). The patient''s concomitant medications were not reported. On 03Feb2021, the patient was unwell. No particular symptoms, no change in general condition or behavior between vaccination and malaise. The patient was hospitalized urgently. An intracranial hematoma was detected. The evolution was rapidly pejorative leading to the death of the patient. The report was under investigation. The patient did not have COVID-19. She had not been tested. The patient died on 03Feb2021. It was unknown if an autopsy was performed. No follow-up attempts possible. No further information expected. Batch/lot number already obtained.; Reported Cause(s) of Death: Intracranial haematoma
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166